Association of Eleven Common, Low-Penetrance Colorectal Cancer Susceptibility Genetic Variants at Six Risk Loci with Clinical Outcome

被引:15
|
作者
Hoskins, Janelle M. [1 ]
Ong, Pei-Shi [1 ]
Keku, Temitope O.
Galanko, Joseph A. [2 ]
Martin, Christopher F.
Coleman, Clint A. [1 ]
Wolfe, Michelle
Sandler, Robert S.
McLeod, Howard L. [1 ,3 ,4 ]
机构
[1] Univ N Carolina, Eshelman Sch Pharm, Inst Pharmacogen & Individualized Therapy, Div Pharmacotherapy & Expt Therapeut, Chapel Hill, NC 27515 USA
[2] Univ N Carolina, Div Gastroenterol & Hepatol, Ctr Gastrointestinal Biol & Dis, Chapel Hill, NC USA
[3] Univ N Carolina, Div Hematol & Oncol, Chapel Hill, NC USA
[4] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
来源
PLOS ONE | 2012年 / 7卷 / 07期
基金
美国国家卫生研究院;
关键词
GENOME-WIDE ASSOCIATION; COLON-CANCER; ALLELIC IMBALANCE; CHROMOSOME; 8Q24; MUTATIONS; PROSTATE; SURVIVAL; SHOWS; MYC;
D O I
10.1371/journal.pone.0041954
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Low-penetrance genetic variants have been increasingly recognized to influence the risk of tumor development. Risk variants for colorectal cancer (CRC) have been mapped to chromosome positions 8q23.3, 8q24, 9p24.1, 10p14, 11q23, 14q22.2, 15q13, 16q22.1, 18q21, 19q13.1 and 20p12.3. In particular, the 8q24 single nucleotide polymorphism (SNP), rs6983267, has reproducibly been associated with the risk of developing CRC. As the CRC risk SNPs may also influence disease outcome, thus in this study, we evaluated whether they influence patient survival. Methodology/Principal Findings: DNA samples from 583 CRC patients enrolled in the prospective, North Carolina Cancer Care Outcomes Research and Surveillance Consortium Study (NC CanCORS) were genotyped for 11 CRC susceptibility SNPs at 6 CRC risk loci. Relationships between genotypes and patient survival were examined using Cox regression analysis. In multivariate analysis, patients homozygous for the CRC risk allele of rs7013278 or rs7014346 (both at 8 q24) were only nominally significant for poorer overall survival compared to patients homozygous for the protective allele (hazard ratio = 2.20 and 1.96, respectively; P < 0.05). None of these associations, however, remained statistically significant after correction for multiple testing. The other nine susceptibility SNPs tested were not significantly associated with survival. Conclusions/Significance: We did not find evidence of association of CRC risk variants with patient survival.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Low-Penetrance Susceptibility Variants in Familial Colorectal Cancer
    Niittymaki, Iina
    Kaasinen, Eevi
    Tuupanen, Sari
    Karhu, Auli
    Jarvinen, Heikki
    Mecklin, Jukka-Pekka
    Tomlinson, Ian P. M.
    Di Bernardo, Maria Chiara
    Houlston, Richard S.
    Aaltonen, Lauri A.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2010, 19 (06) : 1478 - 1483
  • [2] Deciphering the genetic architecture of low-penetrance susceptibility to colorectal cancer
    Whiffin, Nicola
    Dobbins, Sara E.
    Hosking, Fay J.
    Palles, Claire
    Tenesa, Albert
    Wang, Yufei
    Farrington, Susan M.
    Jones, Angela M.
    Broderick, Peter
    Campbell, Harry
    Newcomb, Polly A.
    Casey, Graham
    Conti, David V.
    Schumacher, Fred
    Gallinger, Steve
    Lindor, Noralane M.
    Hopper, John
    Jenkins, Mark
    Dunlop, Malcolm G.
    Tomlinson, Ian P.
    Houlston, Richard S.
    HUMAN MOLECULAR GENETICS, 2013, 22 (24) : 5075 - 5082
  • [3] Low-Penetrance Susceptibility Variants in Colorectal Cancer-Current Outlook in the Field
    Szuman, Marcin
    Kaczmarek-Rys, Marta
    Hryhorowicz, Szymon
    Kryszczynska, Alicja
    Grot, Natalia
    Plawski, Andrzej
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (15)
  • [4] Low-penetrance variants underlying familial colorectal cancer
    Niittymaki, Lina
    Kaasinen, Eevi
    Karhu, Auli
    Jarvinen, Heikki
    Mecklin, Jukka-Pekka
    Tomlinson, Ian Pm
    Houlston, Richard S.
    Aaltonen, Lauri A.
    CANCER RESEARCH, 2010, 70
  • [5] Low-penetrance genes and their involvement in colorectal cancer susceptibility
    de Jong, MM
    Nolte, IM
    Meerman, GJT
    van der Graaf, WTA
    de Vries, EGE
    Sijmons, RH
    Hofstra, RMW
    Kleibeuker, JH
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2002, 11 (11) : 1332 - 1352
  • [6] A genome wide scan to find common, low-penetrance breast cancer susceptibility loci
    Dunning, Alison M.
    JOURNAL OF MEDICAL GENETICS, 2006, 43 : S39 - S39
  • [7] Common low-penetrance risk variants associated with breast cancer in Polish women
    Joanna K Ledwoń
    Ewa E Hennig
    Natalia Maryan
    Krzysztof Goryca
    Dorota Nowakowska
    Anna Niwińska
    Jerzy Ostrowski
    BMC Cancer, 13
  • [8] Common low-penetrance risk variants associated with breast cancer in Polish women
    Ledwon, Joanna K.
    Hennig, Ewa E.
    Maryan, Natalia
    Goryca, Krzysztof
    Nowakowska, Dorota
    Niwinska, Anna
    Ostrowski, Jerzy
    BMC CANCER, 2013, 13
  • [9] Quantifying the cumulative effect of low-penetrance genetic variants on breast cancer risk
    Smyth, Conor
    Spakulova, Iva
    Cotton-Barratt, Owen
    Rafiq, Sajjad
    Tapper, William
    Upstill-Goddard, Rosanna
    Hopper, John L.
    Makalic, Enes
    Schmidt, Daniel F.
    Kapuscinski, Miroslav
    Fliege, Joerg
    Collins, Andrew
    Brodzki, Jacek
    Eccles, Diana M.
    MacArthur, Ben D.
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2015, 3 (03): : 182 - 188
  • [10] Clinical implications of low-penetrance breast cancer susceptibility alleles
    Francis Freisinger
    Susan M. Domchek
    Current Oncology Reports, 2009, 11 : 8 - 14